ADHD Market to Reach Nearly $10 Billion by 2020
The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a key driver of growth, according to GBI Research.
The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a key driver of growth, according to GBI Research.
The company’s new report states that the increase - which represents a Compound Annual Growth Rate (CAGR) of 5.3% and relates to eight major markets (US, UK, France, Germany, Spain, Italy, Japan and Canada) - will occur fastest in Japan, due to the country’s high ADHD prevalence.Diagnosis rates are currently low outside of the US as the disorder is still treated with considerable skepticism, says GBI Research analyst Dale Prior. But this trend is expected to change over the coming decade because of an increased recognition of adult ADHD.
The fifth edition of The Diagnostic and Statistical Manual of Mental Disorders, published last year, broadened the diagnostic criteria for ADHD, recognizing that impairment from symptoms of the disorder may develop in later life.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
